Back
Reshape Lifesciences Stock Price Chart
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
34
RSLS
Reshape Lifesciences
Last Price:
0.16
Seasonality Move:
-15.67%
7 Day Trial
ALL ACCESS PASS
$
7
Hope Is Not a Strategy!
Learn More- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RSLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Reshape Lifesciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.16 | Buy |
| 20-day SMA: | 0.16 | Buy |
| 50-day SMA: | 0.19 | Sell |
| 200-day SMA: | 0.2 | Sell |
| 8-day EMA: | 0.16 | Buy |
| 20-day EMA: | 0.16 | Buy |
| 50-day EMA: | 0.18 | Sell |
| 200-day EMA: | 0.85 | Sell |
Reshape Lifesciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 50.2 | Buy |
| Chaikin Money Flow: | -22576 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.16 - 0.18) | Sell |
| Bollinger Bands (100): | (0.16 - 0.22) | Sell |
Reshape Lifesciences Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Reshape Lifesciences Stock
Is Reshape Lifesciences Stock a Buy?
- Reshape Lifesciences share price is 0.17 while RSLS 8-day simple moving average is 0.16, which is a Buy signal.
- The stock price of RSLS is 0.17 while Reshape Lifesciences 20-day SMA is 0.16, which makes it a Buy.
- Reshape Lifesciences 50-day simple moving average is 0.19 while RSLS share price is 0.17, making it a Sell technically.
- RSLS stock price is 0.17 and Reshape Lifesciences 200-day simple moving average is 0.20, creating a Sell signal.
RSLS Technical Analysis vs Fundamental Analysis
Sell
34
Reshape Lifesciences (RSLS)
is a Sell
Is Reshape Lifesciences a Buy or a Sell?
-
Reshape Lifesciences stock is rated a Sell
The current Reshape Lifesciences [RSLS] share price is $0.17. The Score for RSLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Reshape Lifesciences Stock Info
Market Cap:
4.93M
Price in USD:
0.17
Share Volume:
239.31K
Reshape Lifesciences 52-Week Range
52-Week High:
0.79
52-Week Low:
0.14
Sell
34
Reshape Lifesciences (RSLS)
is a Sell
Reshape Lifesciences Share Price Forecast
-
What is the Reshape Lifesciences stock price today?
The Reshape Lifesciences stock price is 0.17 USD today. -
Will RSLS stock go up or go down?
Reshape Lifesciences> share price is forecast to RISE/FALL based on technical indicators -
Is Reshape Lifesciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reshape Lifesciences is overvalued.
Is Reshape Lifesciences Stock a Buy?
- Reshape Lifesciences share price is 0.17 while RSLS 8-day exponential moving average is 0.16, which is a Buy signal.
- The stock price of RSLS is 0.17 while Reshape Lifesciences 20-day EMA is 0.16, which makes it a Buy.
- Reshape Lifesciences 50-day exponential moving average is 0.18 while RSLS share price is 0.17, making it a Sell technically.
- RSLS stock price is 0.17 and Reshape Lifesciences 200-day simple moving average is 0.85, creating a Sell signal.
Fundamental Analysis of Reshape Lifesciences
Is Reshape Lifesciences a good investment?
- Analysts estimate an earnings decrease this quarter of $1.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.09 per share.
Technical Analysis of Reshape Lifesciences
Should I short Reshape Lifesciences stock?
- RSLS Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Reshape Lifesciences is a Sell
- Reshape Lifesciences Relative Strength Index (RSI) is 50.2, which suggest Reshape Lifesciences is overbought
- The Bollinger Bands (25) for Reshape Lifesciences is (0.16 - 0.18), which suggest Reshape Lifesciences is a Sell
- The Bollinger Bands (100) for Reshape Lifesciences is (0.16 - 0.22), which suggest Reshape Lifesciences is a Sell
* Reshape Lifesciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.